Last updated on June 13th, 2012 at 05:07 pm
The CDC’s Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination of males aged 11 or 12 years with HPV4 administered as a 3-dose series (recommendation category: A, evidence type: 2§). The vaccination series can be started beginning at age 9 years. Vaccination with HPV4 is recommended for males aged 13 through 21 years who have not been vaccinated previously or who have not completed the 3-dose series. Males aged 22 through 26 years may be vaccinated.
HPV has been identified as the cause of certain cervical cancers in women. It also the cause of some throat and mouth cancers along with genital warts in both men and women. The virus is sexually transmitted.
The side effects of the vaccine is nominal, no different than most other vaccines. And soon will hear from the anti-vaccination crowd telling us how HPV is not that bad and there are many risks from the vaccine.
- COVID misinformation campaigns are very profitable - 2024-02-22
- The largest safety study of COVID vaccines finds rare issues - 2024-02-21
- Does drinking alcohol increase the risk of cancer? - 2024-02-19